With COVID-19 cases rising, concerns around treatment delays and coronavirus itself have increased too. But as ever, we’re here for men through this winter.
We've achieved a huge amount for men with prostate cancer throughout the pandemic, thanks to you. We still face huge challenges, but we're more focused on our priorities than ever.
Research labs were closed, men had their treatments delayed, and much of our activity grinded to a halt, but prostate cancer didn’t, so neither did we.
We face a cancer crisis following the pandemic. A few minutes of your time could help to protect decades of prostate cancer research.
We condemn the NICE decision to reject abiraterone, limiting options for older men.
Following the coronavirus crisis, there’s danger of a cancer crisis. Today we launch an action plan calling on 10 Downing Street and NHS England to get cancer services back on track.
Thanks to you, treatments that are as effective as chemotherapy are now available for men to take at home.
New data shows more men are getting access to the best scans for diagnosis, but there's more work to do.
New data shows prostate cancer is the most common cancer in the UK. Here's why it's not all bad news, and what we do next.
Our response to new data showing prostate cancer deaths hit a record high of 12,000 in one year.